Showing results (161-170 of 172) with videos related to
Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2023
Outcomes After Preoperative Chemoradiation With or Without Pazopanib in Non-Rhabdomyosarcoma Soft Tissue Sarcoma: A Report From Children's Oncology Group and NRG OncologyAaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, et al.Lancet (London, England)|November 15, 2024
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trialYvonne M Mowery, Karla V Ballman, Angela M Hong, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 7, 2020
NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021Margaret von Mehren, John M Kane, Marilyn M Bui, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 9, 2022
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022Margaret von Mehren, John M Kane, Richard F Riedel, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2022
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, John M Kane, Mark Agulnik, et al.Cancer|October 28, 2022
Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcomaSantiago A Lozano-Calderón, Jose Ignacio Albergo, Olivier Q Groot, et al.The Lancet. Oncology|July 24, 2020
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trialAaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025Margaret von Mehren, John M Kane, Samantha A Armstrong, et al.Proceedings of the National Academy of Sciences of the United States of America|February 25, 2009
The role of the CD58 locus in multiple sclerosisPhilip L De Jager, Clare Baecher-Allan, Lisa M Maier, et al.Lancet (London, England)|March 30, 2024
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trialSandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, et al.Pageof 18